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PeptidoglycanOP-145, a synthetic antimicrobial peptide developed from a screen of the human cathelicidin LL-37, displays
strong antibacterial activities and is — at considerably higher concentrations — lytic to human cells. To obtain
more insight into its actions, we investigated the interactions between OP-145 and liposomes composed of
phosphatidylglycerol (PG) and phosphatidylcholine (PC), resembling bacterial and mammalian membranes, re-
spectively. Circular dichroism analyses of OP-145 demonstrated a predominant α-helical conformation in the
presence of both membrane mimics, indicating that the different membrane-perturbation mechanisms are not
due to different secondary structures. Membrane thinning and formation of quasi-interdigitated lipid–peptide
structureswas observed in PG bilayers, while OP-145 led to disintegration of PC liposomes into disk-likemicelles
and bilayer sheets. Although OP-145was capable of binding lipoteichoic acid and peptidoglycan, the presence of
these bacterial cell wall components did not retain OP-145 and hence did not interfere with the activity of the
peptide toward PGmembranes. Furthermore, physiological Ca++ concentrations did neither inﬂuence themem-
brane activity of OP-145 in model systems nor the killing of Staphylococcus aureus. However, addition of OP-145
at physiological Ca++-concentrations to PG membranes, but not PC membranes, resulted in the formation of
elongated enrolled structures similar to cochleate-like structures. In summary, phospholipid-driven differences
in incorporation of OP-145 into the lipid bilayers govern the membrane activity of the peptide on bacterial and
mammalian membrane mimics.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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The increasing incidence of multidrug resistant (MDR) bacterial
strains is becoming a signiﬁcant problem for the treatment of various in-
fections. This presses the need for the development of novel antimicro-
bial strategies to combat infections with MDR pathogens [1]. One
strategy has focused on the characterization of naturally occurring as
well as newly designed antimicrobial peptides (AMPs) as a novel class
of antibiotics [2–4]. Some AMPs have already been clinically tested as
a topical treatment [5] and studied for prevention of implant surface
and catheter-associated infections [6,7].
AMPs act in many cases on the lipid matrix of bacterial cell
membranes [8] or have multiple cellular targets [3,9]. Therefore,
the likelihood of emergence of resistance to AMPs is thoughtthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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mechanism of action of many AMPs relates to targeting the micro-
bial cytoplasmic membrane, interacting with the lipid matrix and
subsequent permeabilization of the membrane [10,11]. Their anti-
microbial activity strongly depends on the nature of the peptide
and the lipid composition of the membrane [10]. The plasma
membrane of Gram-positive bacteria contains a high amount of
negatively charged phosphatidylglycerol (PG) [12], while zwitter-
ionic phosphatidylcholine (PC) is the major component of mam-
malian cytoplasmic membranes [13–15]. Hence, afﬁnity to PG and
PC may primarily govern the interactions between antimicrobial
peptides and the membranes of their targets.
One of the best studied AMPs is human LL-37, which belongs to the
cathelicidin peptide family that is conserved amongdiversemammalian
species [16,17]. This peptide family plays an important role in the
immune system and possesses a wide spectrum of activities against
bacteria, fungi, viruses and cancer cells [18]. Its molecular mode of
membrane disruption strongly depends on the target membrane lipid
composition [19–23].
Modiﬁcations in the sequence of LL-37 have been introduced to
improve its bactericidal properties [24,25]. In this context, we have
designed OP-145, previously termed P60.4Ac [26]. In their study, Nell
et al.[26] scanned the LL-37 sequence with a window size of 22 to
25mers identifying a 24mer (amino acid sequence 13–36) as the most
promising segment in terms of antimicrobial activity and with similar
efﬁcacy as LL-37 in terms of LPS and LTA neutralization and lower pro-
inﬂammatory activity. This peptide was then further modiﬁed and
several amino acids were replaced in particular at the C-terminal part
of the peptide to favor the formation of an ideal amphipathic helix. Fur-
thermore, in order to improve the stability of the peptide against pro-
teolytic degradation the N- and C-terminus of OP-145 were blocked
by N-acetylation and C-amidation, respectively. This synthetic peptide
has been proven to be safe and successful as a treatment for chronic
otitis media in a clinical phase I/II trial [27]. One of the most frequent
pathogens associated with this disease is the Gram-positive bacteria
Staphylococcus aureus [28,29] including MRSA which is also a major
pathogen linked to osteomyelitis [30,31]. Thus in the present study,
we focused on the interactions between OP-145 and membrane
model systems mimicking Gram-positive bacterial and mammalian
cytoplasmic membranes in order to obtain better insight into the
mechanism(s) of action of this peptide.
2. Experimental procedures
2.1. Materials
Phospholipids (N99% purity) were obtained fromAvanti Polar Lipids
(Alabaster, AL). ANTS (8-aminonaphthalene-1,3,6-trisulfonic acid,
disodium salt), bodipy-cadaverine and DPX (p-xylene-bis-pyridinium
bromide) were purchased fromMolecular Probes (Eugene, OR). Choles-
terol, LTA and peptidoglycan (PGN) were from Sigma-Aldrich Handels
Gmbh (Vienna, Austria).
OP-145 (acetyl-IGKEFKRIVERIKRFLRELVRPLR-amide) was prepared
by solid phase strategies on an automated multiple peptide synthesizer
(SyroII, MultiSyntech, Witten, Germany) as described previously [32].
The purity of the peptides was N95%, as determined by UPLC–MS
(Acquity, Waters, Milford, MA). Peptide's integrity was conﬁrmed using
MALDI-TOF mass spectrometry (Microﬂex, Bruker, Bremen, Germany),
showing the expected molecular masses. The lyophilized peptide was
stored at−20 °C until use, then dissolved in H2O with 0.01% acetic acid
to a stock of 10 mg/ml, and aliquots were stored at−20 °C.
2.2. Antimicrobial activity
S. aureus JAR060131 [33] was cultured to mid-logarithmic phase
in tryptic soy broth and washed once with PBS. Approximately1 × 106 CFU/ml of PBS were incubated with OP-145 (ﬁnal concentra-
tions: 0–51.2 μM) for 2 h at 37 °C under shaking conditions. Thereaf-
ter, the number of viable bacteria was determined by plating 10-fold
serial dilutions on diagnostic sensitivity agar. Antimicrobial activity
is expressed as the 50% inhibitory concentration (IC50), i.e., the
lowest peptide concentration that killed ≥50% of bacteria.
2.3. Lysis of human dermal ﬁbroblasts
Human dermal ﬁbroblasts (PromoCell GmbH, Heidelberg, Germany)
were cultivated in ﬁbroblast growth media-2 (PromoCell GmbH). All
cells were kept in a 5% CO2 atmosphere at 37 °C. Cells were cultured
to ~90% conﬂuence and then detached by accutase (PAA, Pasching,
Austria). Enzymic activity was stopped with PBS containing 10% fetal
bovine serum. Cells were washed with PBS and re-suspended in the
culture medium. Approximately 1 × 105 cells were incubated with
0–80 μM OP-145 for 1 h at 37 °C. Five microliters of 50 μg/ml
propidium iodide (PI, Invitrogen, Camarillo, CA) was added to the
samples and after 5 min at room temperature in the dark ﬂuores-
cence was measured with a ﬂuorescence spectrometer (SPEX Fluoro
Max-3 spectroﬂuorimeter, Horiba Scientiﬁc, Irvine, CA) using an ex-
citation wavelength (λex) of 536 nm and an emission wavelength
(λem) of 617 nm. Cytotoxicity was calculated from the percentage
of PI-positive cells in medium alone (P0) and in the presence of
peptide (PX) according to Eq. (1):
%PI‐uptake ¼ 100  PX−P0ð Þ
P100−P0ð Þ ð1Þ
whereby Triton-X-100 (2.5%) was used to determine 100% PI-
positive cells (P100). Data are expressed as IC50 values, i.e. the lowest
peptide concentration that lyses ≥50% of the cells.
2.4. Hemolysis
Whole venous blood of healthy volunteers was collected in citrate
tubes. Erythrocytes were isolated by centrifuging the blood for 10 min
at 2000 ×g and subsequently washed twice in PBS. A 0.5% erythrocyte
solution in PBS was exposed to OP-145 (ﬁnal concentrations: 1.6–
51.2 μM) in the presence of 50% human plasma. After 1 h at 37 °C
under static conditions, the erythrocyte suspensions were centrifuged
and the optical density of the supernatants was determined at
415 nm. The percentage of hemolysis was calculated relative to the pos-
itive control (2.5% Triton X-100). Data are expressed as IC50 values, the
lowest peptide concentration that lyses ≥50% of the cells.
2.5. Determination of secondary structure
Secondary structure of OP-145was obtained from circular dichroism
(CD) spectra measured on a Jasco J-715 spectropolarimeter (Jasco,
Gross-Umstadt, Germany) using a 0.02 cm quartz cuvette equilibrated
at 25 °C. Spectra were recorded at 25 °C between 180 and 260 nm
with a 0.2 nm step resolution. The measurements were performed
with 200 μM OP-145 in the presence and absence of large unilamellar
vesicles (LUVs) composed of POPG and POPC, respectively. The
peptide-to-lipid molar ratio was 1:25. The background signal of
10 mM Hepes (pH 7.0) was subtracted from the respective spectra.
Five spectra were averaged before secondary structure contents have
been estimated by CDSSTR program on the online server DICHROWEB
[34].
2.6. Preparation of liposomes
Lipid ﬁlmswere prepared using an appropriate amount of phospho-
lipid solved in chloroform/methanol (9:1 v/v), evaporated under a
stream of nitrogen and stored in vacuum overnight. After addition of
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pH 7.0), formation of lipid vesicles was achieved by intermittent vig-
orous vortexing at a temperature above the phase transition of the
respective phospholipids. In case of samples containing peptide,
LTA or PGN appropriate amounts had been dissolved in PBS prior to
vortex mixing. The preparation of DPPG/LTA vesicles was performed
under sonication. LTA concentration has been calculated with a mo-
lecular weight of 6200 g/mol estimated for 24 repeating units of the
polyglycerolphosphate chain [35]. Large unilamellar vesicles were
obtained by several cycles of extrusion of the hydrated liposomes
through a polycarbonate ﬁlter (Millipore-Isopore™) of 0.1 μm pore
size following a protocol described previously [36].
2.7. Differential scanning calorimetry (DSC)
DSC measurements were performed using a Microcal VP-DSC high-
sensitivity differential scanning calorimeter (Microcal, Northampton,
MA). Scans of 1 mg/ml lipid concentration were recorded at a constant
rate of 30 °C/h and data were analyzed usingMicrocal's Origin software.
Calorimetric enthalpies were calculated by integration of the peak areas
after baseline correction and normalization to themass of phospholipid.
The phase transition temperaturewas deﬁned as the temperature at the
peak maximum.
2.8. Fluorescence spectroscopy and leakage assay
Leakage of the aqueous content of the 8-aminonaphthalene-1,3,6-
trisulfonic acid/p-xylene-bis-pyridinium bromide (ANTS/DPX)-loaded
large unilamellar vesicles (LUVs) composed of POPG, POPG/LTA, POPC
or POPC/cholesterol upon incubation with peptide was determined as
described [36]. In the case of POPG/PGN vesicles, 0.1% PGN has been
added to the 50 μMPOPG large unilamellar vesicles prior to the incuba-
tion with peptide. Fluorescence emission was recorded as a function of
time before and after the addition of incremental amounts of peptide
ranging from 0.125 up to 8 μM, corresponding to peptide-to-lipid
molar ratios from 1:400 to 1:6.25 (0.25–16 mol%). The measurements
were performed on a SPEX Fluoro Max-3 spectroﬂuorimeter (Jobin-
Yvon, Longjumeau, France) combined with Datamax software. Percent-
age of leakage was calculated from the fraction of the leakage (IF)
according to Eq. (2):
I F ¼ F−F0ð ÞFmax−F0ð Þ ð2Þ
where F is themeasuredﬂuorescence, F0 is the initial ﬂuorescencewith-
out peptide, and Fmax is the ﬂuorescence corresponding to 100% leakage
gained by addition of 1% Triton X-100.
2.9. Small- and wide-angle X-ray scattering (SWAXS)
For SWAXS measurements samples of 50mg/ml lipid concentration
were measured on a high-ﬂux laboratory small-angle X-ray scattering
camera S3-Micro (Hecus X-Ray Systems, Graz, Austria) equipped with
a high-brilliance micro-beam delivery system operating at a low
power of 30 W (50 kV and 0.6 mA), with point-focus optics (FOX3D).
The used X-ray wavelength (λ) was 1.54 Å and the small-angle X-ray
scattering (SAXS) curves were recorded with a 1D silicon strip detector
operating in single-photon counting mode (Mythen-1K, Dectris, Baden,
Switzerland) and a 2D hybrid pixel detector (Pilatus 100K, Dectris) in
the angular range 0.1° b 2θ b 8.5° in a distance of 27.7 cm (1D) and of
29.7 cm (2D) from the center of the sample. Additionally, wide-angle
X-ray scattering (WAXS) patterns were measured with a 1D-position
sensitive gas detector (Hecus 50 M, Graz, Austria) within the angular
range of 17° b 2θ b 27°. The incident main-beam was blocked by a pre-
cisely stepper-motor controlled beam-stopper made of a tungsten
blade, located in front of the detector. The calibration of the q-scalewas performed by measuring silver-behenate with a deﬁned lamellar
spacing of 58.38 Å, where q, the reciprocal scattering vector, is related
to the scattering angle 2θ, as given in Eq. (3):
q ¼ 4π
λ
 sin θð Þ: ð3Þ
Background corrected scattering data of DPPGwere evaluated based
on a global analysis technique [37,38], while DPPC was analyzed apply-
ing the Indirect Fourier Transformation method, which evaluates the
particle distance distribution function p(r) in real space by using the
program GNOM [39]. Subsequent modeling of lipid–peptide disks was
performed as described earlier [40].
2.10. Determination of bodipy-cadaverine displacement
The displacement assay has been performed according to Zorko et al.
[41] using 1 μM bodipy-cadaverine and 13 μg of LTA/ml.
2.11. Binding assay for PGN
Binding afﬁnity of OP-145 toward staphylococcal PGN has been test-
ed by themethod described by Torrent et al. [42]. Bovine serumalbumin
(BSA) and lysozyme have been included as negative and positive con-
trols, respectively.
2.12. Neutralization assay
UV-inactivated S. aureus JAR was pre-incubated with 0–3.2 μM OP-
145 for 30 min at 37 °C. Five times diluted whole blood from a healthy
volunteer was stimulated with S. aureus/peptide mixtures, the bacteri-
um, the peptide or no stimulus. After 18 h incubation at 37 °C and 5%
CO2 the levels of the IL-8 in the supernatants were quantiﬁed by ELISA
(Biosource Life Technologies) according to supplier's instructions. The
percentage of inhibition of IL-8 release was calculated as follows:
(1− IL-8 level by S aureus JAR exposed to OP-145 / IL-8 level caused
by S aureus JAR) × 100%.
2.13. Freeze fracture transmission electron microscopy
For freeze fracture electron microscopy, DPPG liposomes were pre-
pared in 10 mM Hepes, 130 mM NaCl, 2.5 mM CaCl2, pH 7.0 at a ﬁnal
concentration of 5 mg/ml lipid in the presence and absence of 2 mol%
OP-145. Five microliters of the liposomal solution were mixed with
30% glycerol (v/v), frozen in liquid propane, and stored in liquid nitro-
gen until further use. Samples were fractured in a Balzers BAF400D
freeze-etching apparatus (Oerlikon Balzers Coating AG, Balzers,
Liechtenstein) under vacuum with a pressure between 1.3 × 10−4 and
1.3 × 10−5 Pa. Replicas were produced by vacuum deposition of plati-
num and carbon on the surface. The replicas were put into a sodium hy-
pochlorite solution for about 3 h and stored overnight in 50% NaOH.
Beforemounting them on a copper grid, replicas were washedwith dis-
tilledwater at least three times. Imageswere takenusing a FEI Tecnai G2
20 transmission electronmicroscope (FEI, Eindhoven, The Netherlands)
with a Gatan ultrascan 1000 CCD camera. Acceleration voltage was
120 kV.
3. Results
3.1. Activity of OP-145 toward bacterial and mammalian cells
Cytotoxic activity ofOP-145was assessed toward bacterial andhuman
cells showing that OP-145 was highly effective against S. aureus, as N50%
of bacteriawere killedwithin 1 h at 0.8–1.6 μM.As expected, considerably
higher concentrations of the peptidewere required to lyse humandermal
Table 1
Thermodynamic parameters (pretransition and main phase transition temperature
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and ≥102.4 μM, respectively.(Tpre/Tm) and corresponding enthalpies (ΔHpre/ΔHm)) of DPPG bilayers in the
absence and presence of OP-145. Data are the representative results of three indepen-
dent experiments with standard deviations less than 5%.
OP-145
(mol%)
Heating Cooling
Tpre
(°C)
ΔHpre
(kcal/mol)
Tm
(°C)
ΔHm
(kcal/mol)
Tm
(°C)
ΔHm
(kcal/mol)
0 34.4 1.6 41.0 10.9 40.8 10.0
0.25 34.3 0.7 41.2 10.9 41.0 11.0
0.5 33.7 0.7 41.1 10.6 41.0 11.0
1 34.1 0.9 41.3 13.3 40.8 8.3
39.8a 3.7a
2 34.0 0.8 41.3 12.3 40.9 7.13.2. Structural properties of OP-145
CD experiments revealed no deﬁned secondary structure of OP-145
in 10 mMHepes. However, a predominant α-helical conformation was
detected for OP-145 when analyzed in the presence of lipid bilayers,
POPG and POPC, respectively (Fig. 1). The fraction of α-helix differed
only slightly between POPG and POPC, suggesting that the ability of
the peptide to discriminate between bacterial and mammalian mem-
branes is not due to different secondary structures of OP-145.39.0a 5.0a
4 36.2 0.5 41.2 12.7 41.0 4.3
38.4a 8.3a
a Peptide-enriched domains.
3.3. Interaction of OP-145 with bacterial membrane mimic
The interaction of OP-145 with liposomes composed of 1,2-
dipalmitoyl-phospatidylglycerol (DPPG), a bacterial membrane
mimic, was assessed by differential scanning calorimetry (DSC) as
well as by small and wide angle X-ray scattering (SAXS and
WAXS) techniques. DSC revealed that the thermotropic phase be-
havior of DPPG was characterized by two phase transitions, which
can be attributed to the pre-transition from the lamellar gel (Lβ′)
to the ripple phase (Pβ′) at 34.4 °C and the main or chain-melting
transition from the Pβ′ to the ﬂuid phase (Lα) at 41 °C in agreement
with published data [19] (Table 1). Upon cooling DPPG from the
ﬂuid to the gel phase, a minor hysteresis of the main transition
(Tm = 40.8 °C) was observed. In the presence of OP-145, the
heating scans showed a minor increase of the main transition tem-
perature accompanied with a strong tailing toward the high tem-
perature side at low and the rise of a shoulder at high peptide
concentrations (data not shown). In addition, the main transition
enthalpy is increased by about 20% with increasing peptide
concentration (Table 1). These observations suggest the occurrence
of twophase transitions,whichwasmore prominently seen in the cooling
scans,where a phase separation into peptide-enriched and -poor lipid do-
mainswas clearly observed (Fig. 2A). The two phase transitions still over-
lap at lower peptide concentration but started to separate above 1 mol%
OP-145. No changes in the transition temperature of the peptide-poor
(largely unperturbed) DPPG domain were observed, while the transition
temperature of peptide-enriched (strongly affected) DPPG domains
shifted to lower values (Fig. 2A, Table 1). As can be deduced from the en-
thalpy of these transitions, the fraction of peptide-poorDPPGdomains de-
creasedwith increasing peptide concentration, which correlatedwith the
elevating fraction of the peptide-enriched DPPG domain.Fig. 1. Structural properties of OP-145. A) CD spectra of 200 μMOP-145 inHepes buffer solution
respectively. B) Respective fraction of secondary structure at indicated conditions.In the gel phase (25 °C) the SWAXSpatterns of pure DPPG liposomes
were characteristic for positionally weakly correlated bilayers of
oligolamellar vesicles in the Lβ′-phase with tilted hydrocarbon chains
(Fig. 2C/D). Applying a full-q range global ﬁtting model [37,38] a lamel-
lar repeat distance (d-spacing) of 107.5 Å and a phosphate–phosphate
distance of 45.3 Å were calculated (Fig. 2C, Table 2). In the presence of
2 mol% OP-145, SWAXS patterns were obtained that largely resembled
the features of DPPG in the presence of LL-37 [19]. The quasi-Bragg
peak was hardly discernible and the diffuse scattering as well as
increase of lamellar d-spacing to 177.5 Å indicate loss of correlation be-
tween the bilayers, which was more clearly detected in cooling scans.
Moreover, the SAXS pattern showed additional diffuse scattering
around q = 0.2 Å−1 (Fig. 2C). In this q-range a reasonable but not per-
fectﬁt could be obtained,when theX-ray curvewas analyzed based on a
single bilayer structure, which is also indicative for the presence of a
second coexisting structure. Most importantly, a reduced phosphate–
phosphate distance (dPP) of about 40.9 Å (Table 2) was estimated,
which suggests the presence of a thinner quasi-interdigitated bilayer
structure like in the case of LL-37. The wide-angle X-ray data further
support this assumption showing a loss of tilt in hydrocarbon chain
packing. Now a single symmetric peak at q = 1.51 Å−1 (d = 4.16 Å)
was dominant (Fig. 2D), characteristic for hexagonally packed hydro-
carbon chains oriented perpendicular to the bilayer plane as observed
for interdigitated bilayers [43]. In addition, the increased total enthalpy
measured for DPPG in the presence of OP-145 is in agreement with the
formation of an interdigitated structure [44,45]. Also in the physiologi-
cally relevant ﬂuid phase, the DPPG bilayer was noticeably thinner in
the presence of OP-145 (dPP = 37.1 Å as compared to dPP = 39.7 Å of(black line), in the presence of 5mMPOPG (ﬁlled squares) and 5mMPOPC (open circles),
Fig. 2. Effect of OP-145 on bacterial membrane mimics. A) Concentration dependent thermotropic behavior of DPPG vesicles in the presence of OP-145 as observed in DSC cooling scans.
B) Leakage of POPG LUVs at indicated OP-145 concentration. C) SAXS and D) WAXS of DPPG in the presence of 2 mol% OP-145 (gray, bottom) at 25 °C upon cooling. The corresponding
proﬁles of pure DPPG at 25 °C are shown in black. Solid lines in SAXS diagram represents the full q-range ﬁts of the experimental curves shown as circles.
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mixtures [20]. In summary, the DSC and X-ray data demonstrated that
OP-145, like other α-helical peptides such as LL-37, PGLa or mellitin
[19,20], induces a quasi-interdigitated membrane structure in the gel
phase and membrane thinning in the ﬂuid phase in a bacterial mem-
brane model.
To test bilayer permeability of our model system, we used large
unilamellar vesicles composed of POPG loaded with ANTS/DPX and in-
cubated them with OP-145 at 37 °C. Release of entrapped ﬂuorescence
marker molecules from POPG was observed already at low concentra-
tions tested and almost full leakage was achieved at 4 mol% (=2 μM)
OP-145. At a total concentration of 1 μMOP-145 50%membrane leakage
from POPG vesicles was obtained (Fig. 2B), which is in the range of the
IC50 (1.6 μM) value for the killing of S. aureus.
3.4. Interaction of OP-145 with LTA and PGN
Next, we investigated the impact of LTA and PGN on the interaction
of OP-145with the bacterial membranemimic, DPPG. In the presence of
1.2 mol% LTA a very broad phase transition regime with two major
peaks at 41.7 °C and 47.2 °C was observed (Fig. 3A, left panel), whereby
the ﬁrst peak corresponds to highly enriched DPPG domains in accor-
dance with previously published data [46]. In the case of DPPG/PGN
(0.1 wt.%) mixtures, the main transition showed rather a dominant
shoulder at the high temperature side than a second phase transition,
which may be due to binding of PGN to the PG surface (Fig. 3A, right
panel). In both the PGN and the LTA-containing liposomes addition of
OP-145 (2 mol%) resulted in the disappearance of the second transition
or the shoulder, indicating that the peptide interacts preferentially with
the LTA as well as PGN enriched bilayer domains. Concomitantly, an in-
crease of the fraction of DPPG undergoing themain phase transitionwas
observed suggesting that part of the DPPG is displaced from DPPG/LTA
or DPPG/PGN domains. The bilayer permeability of our model system
in the presence of LTA or PGN has been tested with ANTS/DPX loaded
large unilamellar vesicles composed of POPG and LTA at a molar ratioTable 2
Lamellar spacing (d) and phosphate–phosphate distance (dPP) of DPPG in the absence and
presence of 2 mol% OP-145. Data are the representative results of three independent
experiments with standard deviations less than 5%.
T
(°C)
Pure ±2 mol% OP-145
dPP (Å) d (Å) dPP (Å) d (Å)
DPPG
25 (gel phase) 45.3 100.9 43.1 100.4
50 (ﬂuid phase) 39.7 116.4 37.1 110.9
25 (gel phase)a 44.1 107.5 40.9 177.5
a Represents the gel phase upon cooling of the ﬂuid phase.of 9:1 to be consistentwith the biological distribution of those two lipids
in S. aureusmembrane [47] and ANTS/DPX loaded POPG vesicles in the
presence of 0.1%weight PGN. Interestingly, leakage fromPOPG/LTA ves-
icles but not from POPG/PGNwas reduced by about 25% in the presence
of OP-145 indicating a slight hindrance of the penetration of OP-145 by
the presence of LTA in the liposome (Fig. 3B).
The probability of OP-145 to bind to LTAwas conﬁrmed in a ﬂuores-
cence assay using bodipy-cadaverine showing that at 0.1 μM OP-145
more than 80% of the ﬂuorophore was displaced (Fig. 3C). Moreover,
OP-145 can also bind to PGN as assessed in a binding assay by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Similar
to the positive control lysozyme,which strongly binds to PGN, themajor
fraction of OP-145 was recovered together with the PGN insoluble frac-
tion in pellet (Fig. 3C). OP-145 was not found in the pellet, when the
binding assay was performed in the absence of PGN (data not shown)
and only traces were found in samples with BSA, which was used as a
control for molecules that do not bind to PGN.
Staphylococcal LTA and PGN are also potent stimuli of cytokine
releaseand important mediators of inﬂammation [48]. Thus in addition,
neutralization assays were performed showing that OP-145 inhibited
dose-dependently the production of IL-8 by whole blood cells in re-
sponse to UV-inactivated S. aureus. Already 0.05 μM peptide was sufﬁ-
cient to inhibit two-thirds of the stimulated IL-8 production and about
90% was inhibited in the presence of 1.6 μMOP-145 (Fig. 3D). No effect
on IL-8 production was detected, when OP-145 was incubated in PBS
without stimulating the whole blood cells with UV-inactivated
S. aureus (data not shown). This further suggests that the high bind-
ing capacity of OP-145 to LTA and PGN plays a role in its immune-
modulatory activity to neutralize the bacterial cell wall components
and inhibit cytokine production. The potential of OP-145 to neutral-
ize LTA has also been reported by Nell et al.[26].
3.5. Interaction of OP-145 with mammalian model system
In order to assess the effect of OP-145 on mammalian membrane
model system, we used multilamellar vesicles (MLVs) composed of
DPPC. The thermotropic phase behavior of DPPC was characterized by
two phase transitions being attributed to the pre-transition from the
lamellar gel (Lβ′) to the ripple phase (Pβ′) at 35.1 °C and the main or
chain-melting transition from the Pβ′ to the ﬂuid phase (Lα) at 41.7 °C
(Fig. 4A, Table 3). Upon incubation with OP-145, the thermotropic
behavior of DPPC was strongly altered. The enthalpy of the pre- and
main transition of DPPC decreased, whereas their transition tempera-
tures and half-width were unaffected (Fig. 4A, Table 3). Above 2 mol%
OP-145 a broad low cooperative transition resulting from peptide-
enriched DPPC domains underlying the sharp main transition evolved,
which increased in enthalpy upon higher peptide concentrations.
Fig. 3. Effect of OP-145 on bacterial cell wall components, LTA and PGN. A) Thermotropic behavior of DPPG/LTA vesicles (left panel) and DPPG/PGN vesicles (right panel) in the presence of
2 mol% OP-145 (II). The corresponding DSC thermograms of pure DPPG with and without LTA (left panel) or PGN (right panel) are shown in black/gray (I). B) Leakage of POPG/LTA LUVs
(black bars) and POPG/PGN (white bars). Dashed lines indicate leakage of pure POPG at respective OP-145 concentration. C) Displacement of Bodipy-cadaverine from LTA in the presence of
indicated OP-145 concentration (left panel) and PGN binding of OP-145 as analyzed by gel electrophoresis (right panel). Lysozymewas used as a positive control and BSA as a negative control.
Lysozyme or OP-145 bound to PGN is detected in the pellet, while unbound protein remains in the supernatant. D) IL-8 production bywhole blood cells in response to 2.5 × 106 CFU/ml of UV-
inactivated S. aureus JAR in the presence of 0–3.2 μMOP-145. Values are mean IL-8 levels in ng/ml of duplicates of one donor.
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mogram revealed a minor fraction of peptide unaffected DPPC bilayers.
Based on the estimation of the enthalpy of the sharp and broad compo-
nent, we concluded that ~10% DPPC MLVs were still present. Both the
low enthalpy and cooperativity of the underlying transition indicated
the presence of small lipid–peptide aggregates which suggests a
detergent-like action of OP-145 leading to disintegration of the
multilamellar PC liposomes as also reported for LL-37 [19].
Permeability of PC bilayers in the presence of OP-145 was measured
using POPC vesicles. Whereas addition of 2 mol% of OP-145 to the bacte-
rial mimetic system POPG induced 50% leakage, this value was not
reached for POPC vesicles even at the highest concentration of OP-145
tested (Fig. 4B). Moreover, the leakage of POPC is attenuated in the pres-
ence of 25 mol% cholesterol.
SAXS data revealed the typical pattern of multilamellar DPPC vesicles
with characteristic Bragg peaks up to the 5th order in the gel phase. In
good agreement with published values [20,49], a lamellar repeat distance
of 64.6 Å as well as a phosphate–phosphate distance of 43.4 Å was calcu-
lated for DPPC vesicles in the gel phase (Fig. 4C/D). In the gel phase in the
presence of 2 mol% OP-145 the SAXS pattern was characterized by the
loss of Bragg peaks and occurrence of a strong diffuse scattering as well
as by a broad weak peak around q = 1.47 Å−1 (d = 4.27 Å) in the
wide-angle region, the latter indicating a loss of hydrocarbon chain pack-
ing order. These observations suggested that, alike LL-37, the peptide
leads to disintegration of the multilamellar DPPC arrangement and that
the diffuse scattering arises from small lipid–peptide particles. Indeed,
data evaluation and modeling of the SAXS patterns of the gel phase
yielded disk-like particles with an estimated maximum diameter of
about 500 Å and a thickness representing the lipid-bilayer of about 60 Å
(Fig. 5). The lipid-core itself is modeled by a disk with dimensions480 × 60 Å. Additionally to this lipid core, an outer peptide layer of a
width of 10 Å with an electron density approximately matching that of
the phospholipid headgroup was added radially, thus resulting in a disk
with the total dimensions of 500 × 60 Å.
Data evolution and modeling of the experimental SAXS-curve in the
ﬂuid phase (50 °C) was performed using a two-dimensional bilayer
model with an electron density across the bilayer perpendicular to its
plane and a bilayer thickness of 45.5 Å, a phosphate–phosphate distance
of 37.8 Å and a hydrocarbon chain length of 15Å (Fig. 5A). Themodeling
revealed that the lateral dimensions of the bilayer are beyond resolution
of this method and thus can be considered as inﬁnitely large as com-
pared to the bilayer thickness suggesting that the disk-like micelles
fuse into large bilayer sheets (Fig. 5A). Minor amounts of multilamellar
DPPC aggregates are still present as can be deduced from the small
Bragg peak at position q = 0.092 Å−1 in agreement with DSC data.3.6. Effect of calcium on the membrane activity of OP-145
As small amounts of Ca2+-ions can drastically raise the phase transi-
tion of anionic membrane lipids [50] we determined the effect of phys-
iological calcium concentrations (Ca++/lipid = 1/0.5) in the presence
and absence of OP-145 on both the bacterial and mammalian mimetic
system. Results revealed that the main transition of DPPG shifted dras-
tically to higher temperatures by about 15 °C (Tm = 55.7 °C) (Fig. 6B),
while Ca++ did not signiﬁcantly affect the thermotropic behavior of
DPPC (Fig. 6A). The thermograms for DPPC in the presence of 2 mol%
OP-145 were practically identical with and without Ca++ (see Figs. 4A
and 6A) indicating that the divalent cation does not affect the interac-
tion of the peptide with zwitterionic lipid.
Fig. 4. Effect of OP-145 on mammalian membrane mimics. A) Concentration dependent thermotropic behavior of DPPC vesicles in the presence of OP-145 as observed in heating scans.
EnlargedDSC data for 2mol%OP-145 is shown in inset. B) Leakage of LUVs composed of POPC (ﬁlled squares) and POPC containing 25mol% cholesterol (open squares) at indicatedOP-145
concentration. C) SAXS and D) WAXS of DPPC in the presence of 2 mol% OP-145 (in gray) at 25 °C. The corresponding proﬁles for pure DPPC at 25 °C are shown in black.
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where an exothermic component at higher temperature upon incubation
with OP-145 was detected. Such behavior was observed with negatively
charged phospholipids at Ca++:lipid molar ratios higher than 1:2 and
was attributed to the formation of cylindrical structures like cochleate cyl-
inders [50,51]. We used Ca++ concentrations below this molar ratio and
thus in the pure lipid system we observed only an increase in transition
temperature resulting from charge neutralization of the phospholipid,
as a consequence of decreased intramolecular repulsion [52]. Electron
microscopy conﬁrmed that pure DPPG in the presence of Ca++ stillTable 3
Thermodynamic parameters (transition temperature (Tm), and enthalpy (ΔHm)) of
the main transition of DPPC in the absence and presence of OP-145. Data are the
representative results of three independent experiments with standard deviations
less than 5%.
OP-145
(mol%)
Tm
(°C)
ΔHm
(kcal/mol)
0 41.7 8.0
0.25 41.7 7.5
0.5 41.5 7.9
1 41.7a 6.9
2 41.5a 5.3
4 41.6a 2.4
a Broad transition underlying the sharp main transition.forms oligolamellar vesicles, while upon addition of OP-145 rather elon-
gated enrolled structures similar to cochleate cylinders were found
(Fig. 6C). Although OP-145 induced completely different morphological
changes ofDPPGmembranes in the presence of calcium, this hadno inﬂu-
ence on its bactericidal activity toward S. aureus, i.e. its antimicrobial ac-
tivity was not impaired up to 10 mM CaCl2 (data not shown).4. Discussion
A general mechanism of bacterial killing by a number of cationic
AMPs is thought to be due to targeting anionic phospholipids on the
membrane surface, which leads to membrane perturbation, eventually
rupture and cell death. S. aureus mainly contains negatively charged
PG in the plasma membrane [12], while zwitterionic PC is the major
component of the mammalian outer membrane [13,14]. In this context,
themainﬁndingof the present study is that thenature of the interaction
of OP-145 with Gram-positive bacterial and mammalian model mem-
branes is governed by the phospholipids. OP-145 induces membrane
thinning in bacterial and a detergent-like action on mammalian mem-
branemimics. Secondary structure of the peptidemay not be a determi-
nant in the discrimination between the bacterial andmammalianmodel
membranes as CD measurements revealed no signiﬁcant differences in
α-helical content of OP-145 in bacterial and mammalian membrane
mimics, which also has been suggested earlier for LL-37 [53].
Fig. 5.Modeling of the DPPC membranes in the presence of OP-145. A) SAXS pattern of
DPPC in the presence of 2 mol% OP-145 at 25 °C (gel phase, open circles) and 50 °C
(ﬂuid phase, open squares) with corresponding two-dimensional (inﬁnitely) bilayer
model with ﬁtted axial electron density (black line), resulting in a bilayer thickness of
45.5 Å, dPP of 37.8 Å and chain length of 15 Å. The scattering curves (50° and 25°, respec-
tively, are shifted vertically for better clarity). B) Distance-distribution function p(r) of
DPPC membranes in the presence of 2 mol% OP-145 (open circles) at 25 °C upon cooling.
The calculated p(r)-function of a model consisting of a bilayer-disk model with dimen-
sions of 60 × 480 Å, with an axial electron-density step proﬁle as shown in the insert,
and a surrounding 10 Å circular ring (electron-density 10% lower than the headgroups
representing the peptide) is shown as a gray line.
Fig. 6. Effect of Ca++onOP-145 interactionwithmodelmembranes. Thermotropic behav-
ior of DPPC (A) and DPPG (B) vesicles in the presence of 2.5mMCaCl2 and 2mol% OP-145
(II). The corresponding DSC thermograms of pure lipidswith andwithout CaCl2 are shown
in black/gray (I). C) Electron micrographs of freeze fracture replicas of 50 μMDPPG in the
presence of 2.5mMCaCl2with 2mol%OP-145 or no peptide at 25 °C (gel phase) and 65 °C
(ﬂuid phase).
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tures (cylindrical shape, chain tilt and thermodynamic behavior)
and that the only marked difference is the charge of the head group
of the phosholipids, the different mode of action of OP-145 might
be provoked by the different penetration depth of the peptide
in the two membrane models. Thus, electrostatic interactions
between the cationic peptide and the anionic lipid head groups
inhibit deeper insertion into the acyl chain region of PG mem-
branes [54]. Hence, the observed thinning of the PG bilayer, i.e. for-
mation of a quasi-interdigitated structure in the gel-phase, results from
the larger “void” created below the peptide attracting the opposing lipid
monolayer, as described in the “free” volume (void) model of membrane
perturbation by antimicrobial peptides [10]. In contrast, the deeper pene-
tration of OP-145 in neutral DPPC bilayers leads to disintegration and for-
mation of disk-like micelles. Micellization of PC bilayers has also been
reported for other toxic peptides, such as δ-lysin or melittin, and deter-
gents [40,55–57]. Support for this model comes also from earlier experi-
ments on the lipid chain-length dependence on the induction of a
quasi-interdigitated structure by antimicrobial peptides such as LL-37,
PGLa and melittin, which demonstrated that reducing the chain length
in PG bilayers hindered and vice versa increasing the chain length in PC
bilayers promoted the fraction of this peculiar structure [19]. For exam-
ple, formation of disk-like micelles by LL-37 was not observed for the
longer-chain distearoyl-PC and diarachidoyl-PC. In contrast, a coexis-
tence of interdigitated and non-interdigitated lipid domains was
observed.As discussed by Freire et al. [58] it is a pertinent question whether
bacterial cell wall components serve as electrostatic barriers capturing
AMPs and in turn preventing their interaction with the cytoplasmic
membrane. They conclude that in the end this is a matter of concentra-
tions of AMPs andmembrane components as well as of afﬁnity of AMPs
toward the different membrane components. Indeed, our data clearly
indicate that OP-145 can also bind to the bacterial cell wall components
LTA and PGN. Leakage experiments demonstrated that PGN did not
impair the capacity of OP-145 to permeabilize PG membranes, which
was slightly reduced by thepresence of LTA. Thus, OP-145 is still capable
to reach the PG lipid bilayer so that membrane permeabilization is not
hindered by these molecules.
Given the importance of divalent cations in membrane physiology
and activity of antimicrobial peptides [59,60], we also studied the effect
of OP-145 on the two model systems in the presence of physiological
Ca++ concentrations. Whereas no signiﬁcant changes for zwitterionic
phospholipids were observed, Ca++ had a major impact on the
2445N. Malanovic et al. / Biochimica et Biophysica Acta 1848 (2015) 2437–2447morphology and phase transition properties of the anionic phospho-
lipids. Owing to the strong electrostatic repulsion at low ionic strength,
anionic lipids destabilize bilayers by allowing the hydrophilic surface to
acquire a high curvature, thus leading to smaller particles. These effects
on anionic phospholipids were diminished at higher salt concentra-
tions, resulting in formation of large sealed vesicular structures [61]. In
general, cations may directly protonate the phospholipids or compete
with the phospholipid polar group for water leading to an increase in
phase transition temperature [52]. All these features (dehydration,
membrane curvature) enhance the formation of elongatedmultilayered
cylindrical structures [50], further referred to as cochleates. At physio-
logical Ca++ concentrations (2.5 mM CaCl2), we observed such a
cochleate formation only after addition of OP-145 to DPPG. Presumably,
OP-145 facilitates the bridging of anionic DPPG molecules in the pres-
ence of Ca++ as the positive charges of the amphipathic OP-145 are ex-
posed in a close distance along one side of the α-helix. It is highly
plausible that the peptide may preferentially interact along the helix
with phospholipid head groups of the planar bilayer that is enabled
to wrap around the incorporated peptide molecules in cylinders,
which are characterized rather by an elliptical than circular cross
section as compared to the “spirally twisted snail's shell” shown for
calcium induced PG [62] and phosphatidylserine cochleates [51].
Epand et al. [63] reported on several antimicrobial cationic oligo-
acyl-lysyl peptide mimics that can form cochleates also in the ab-
sence of divalent cations and that their assembly was favored by in-
creased hydrophobicity and disfavored by extending the distance
between the cationic groups. Cochleate structures found in the pres-
ence of oligo-acyl-lysyl peptide mimics are also not as tightly rolled
up as the Ca++-bridged cochleates of PG [64]. As described above
under our experimental conditions these structures were only ob-
served in the presence of Ca++. In this respect it should be noted
that addition of low mM concentrations of Ca++ can lead to de-
creased activity of AMPs [65]. Although our experimental approach
does not allow making conclusions in terms of displacement of
Ca++ by OP-145, calorimetry and electron microscopy clearly
showed that in the presence of physiological Ca++ concentrations
the peptide interferes with membrane structure in accordance with
the antimicrobial activity observed even at elevated Ca++ levels
(up to 10 mM).
OP-145 exhibits potent antimicrobial activity against S. aureus with
LC99.9% values of 1.6 μM (LC99.9% = lowest peptide concentration that
resulted in N99.9% killing of S. aureus), while disruption of the respective
model membrane DPPG by OP-145 was induced at about 2-fold higher
total peptide concentration (full leakage at 4 μM). The correlation
between vesicle permeabilization and antimicrobial activity has been al-
ready discussed in detail [11,66–69]. Recently, several biophysical tech-
niques have been translated to studies using live bacteria, which allow a
correlation of data gained from liposome-based and cell-based studies
[70]. In this context, Roversi et al. [71] showed an extremely high cover-
age of both leaﬂets of the outer and inner Escherichia colimembranes
by PMAP-23, a cationic amphipathic helix from the cathelicidin fam-
ily. Bacterial killing started at amolar ratio of bound peptide per lipid
of about 1:30 and all bacteria were killed at a molar ratio of 1:4, cor-
responding closely to those estimated by Castanho and co-workers
[70] for other peptides, based on the partition constants derived
from binding studies on model membranes. This emphasizes that
the critical parameter deﬁning the correlation between model sys-
tems and bacterial killing is not the total peptide concentration in
the assay but the membrane-bound peptide-to-lipid ratio.
The impact of membrane partitioning of peptides can also be
deduced from our experiments using PC to mimic mammalian mem-
branes. OP-145 showed a detergent-like mode of action by nearly
complete disruption of PC bilayer as deduced from X-ray and DSC
experiments, but membrane permeabilization did not exceed 30% at
the highest total peptide concentration used (8 μM). The different
extent of membrane perturbation can be explained by the differentexperimental protocols used for DSC/X-ray scattering and leakage stud-
ies. In the former caseOP-145 is a component of the hydration buffer, i.e.
is already present during the process of lipid hydration,which facilitates
direct interaction of the peptide with fatty acyl chains of the phospho-
lipids favoring partitioning of the amphipathic peptide into the bilayer,
while in the latter case the peptide interacts with the preformed lipid
vesicle and has to overcome the interfacial barrier. Thus, only at a ﬁrst
glance, membrane selectivity observed in leakage experiments (almost
100% for POPG vs. about 12% for POPC at a total peptide concentration of
2 μM) seems to be contradictive to the mode of action, detergent-like
disruption for PC bilayers as compared to bilayer thinning for DPPG,
but rather reﬂects different membrane partitioning of OP-145. More-
over, the presence of cholesterol in POPC liposomes further reduced
membrane permeabilization. This is in agreement with earlier reports
that this essential mammalian membrane component attenuates the
binding of AMPs [72–74] including LL-37 [75] concomitantly reducing
toxicity of AMPs, which would be in accordance with observations
that OP-145 was found to be safe in pig guinea, rabbits and rats, and
primary skin and eye irritation/corrosion study, ototoxicity as well as
after intravenous administration [26].
In summary, the present results demonstrate that the nature of the
interaction of OP-145withmodel membranes (bacterial andmammali-
an cell membranes) is directed by the phospholipids. OP-145 induces
membrane thinning in bacterial and a detergent-like action onmamma-
lian models, thus sharing the same mechanistic features as its naturally
occurring parent peptide LL-37. The same mechanistic features were
also reported for other amphipathic α-helical peptides such as the
frog skin peptide PGLa, the bee venom toxin melittin or LL-37 [19]
fromwhich the synthetic peptide OP-145was developed by a screening
approach. Furthermore, the bacterial cell wall components, PGN and
LTA seemingly do not retain OP-145 and hence do not hinder OP-145
to interact and permeabilize the cytoplasmic membrane.
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